Home > Insider Trading > Filing (0001562180-21-007900)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1636422	Health Catalyst Inc.	HCAT	Services-Computer Programming, Data Processing, Etc. (7370)	453337483

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1780978	Paul Horstmeier	C/O Health Catalyst, Inc. 10897 South River Front Parkway, #300 South Jordan UT 84095	Chief Operating Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-12-06	6,063	$15.84	105,243	No	4	M	Direct
Common Stock	Disposition	2021-12-06	600	$37.97	104,643	No	4	S	Direct
Common Stock	Disposition	2021-12-06	2,674	$38.76	101,969	No	4	S	Direct
Common Stock	Disposition	2021-12-06	2,789	$39.89	99,180	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-12-06	6,063	$0.00	6,063	$15.84

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
52,028		2029-02-05	No	4	M	Direct

Footnotes

Due to a technical and administrative error, the original Form 4, filed on December 7, 2021, incorrectly reflected a sale of shares of Common Stock by the Reporting Person attributed to a vesting of Restricted Stock Units. We were recently made aware that the Reporting Person exercised options and sold shares from that option exercise. The exercise of those options and sale of shares is correctly reflected herein and the correct ownership tabulations are also included herein.
The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 15, 2020, in accordance with Rule 10b5-1.
Represents the weighted average sale price of the shares sold ranging from $37.47 to $38.43 per share, inclusive.
Represents the weighted average sale price of the shares sold ranging from $38.47 to $39.24 per share, inclusive.
Represents the weighted average sale price of the shares sold ranging from $39.66 to $40.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (3) through (5).
25% of the 186,467 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023.